Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
2.53
Oct 30 • 3:59 PM ET Dollar change-0.11 Percentage change(-4.17%)
Aftermarket Close
2.51
Aftermarket • 7:59 PM ET Dollar change-0.02 Percentage change(-0.79%)
Oct 29, 2:55 PMTilray launches U.S. beverage transformation plan targeting $20 million in annualized cost savings by fiscal 2028
Index
-
Market Cap
373.90M
Enterprise Value
507.76M
Income
-164.22M
Sales
963.10M
Book/sh
11.29
Cash/sh
1.50
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
3595
IPO
Jul 19, 2018
P/E
-
Forward P/E
-
PEG
-
P/S
0.39
P/B
0.22
P/C
1.69
P/FCF
-
EV/EBITDA
49.93
EV/Sales
0.53
Quick Ratio
1.11
Current Ratio
1.88
Debt/Eq
0.23
LT Debt/Eq
0.17
Option/Short
Yes / Yes
EPS (ttm)
-1.40
EPS next Y
-0.21
EPS next Q
-0.16
EPS this Y
48.39%
EPS next Y
63.43%
EPS next 5Y
67.72%
EPS past 3/5Y
64.12% 39.71%
Sales past 3/5Y
13.44% 12.28%
EPS Y/Y TTM
93.85%
Sales Y/Y TTM
15.93%
EPS Q/Q
-10683.33%
Sales Q/Q
22.74%
Insider Own
1.59%
Insider Trans
0.64%
Inst Own
9.78%
Inst Trans
2.94%
ROA
-7.45%
ROE
-10.38%
ROIC
-8.64%
Gross Margin
26.82%
Oper. Margin
-6.28%
Profit Margin
-17.05%
SMA20
-18.96%
SMA50
-33.24%
SMA200
-53.76%
Trades
Shs Outstand
147.79M
Shs Float
145.44M
52W High
15.70 -83.88%
52W Low
2.62 -3.44%
Volatility
4.51% 5.01%
ATR (14)
0.16
RSI (14)
18.44
Beta
2.01
Rel Volume
1.20
Avg Volume
4.11M
Volume
4,930,325
Perf Week
-9.96%
Perf Month
-29.13%
Perf Quarter
-45.47%
Perf Half Y
-58.93%
Perf YTD
-71.98%
Perf Year
-80.39%
Perf 3Y
-85.38%
Perf 5Y
-97.54%
Perf 10Y
-
Prev Close
2.64
Price
2.53
Change %
-4.17%
Consensus
Buy
Avg. Price Target
$5.72
Implied Upside
+126.1%
Analysts14incl. previous ratings
Rating Distribution4 Buy · 7 Hold · 3 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Apr 02, 2026Upgrade
RRoth Capital
Neutral → Buy$10+295.3%
Jan 27, 2026Initiated
CCanaccord Genuity
Hold
Apr 05, 2024Reiterated
AAlliance Global Partners
Neutral$2.25 → $2.75+8.7%
Nov 02, 2022Initiated
BBernstein
Mkt Perform$3.90+54.2%
Jul 29, 2022Downgrade
TThe Benchmark Company
Hold → Sell$3+18.6%
Mar 04, 2022Upgrade
CCanaccord Genuity
Hold → Buy$9+255.7%
Nov 18, 2021Initiated
BCS logoBBarclays
Underweight$10+295.3%
Nov 01, 2021Downgrade
CCantor Fitzgerald
Overweight → Neutral$18 → $11.80+366.4%
Jun 11, 2021Downgrade
CCIBC
Sector Outperform → Neutral$25+888.1%
Jun 03, 2021Upgrade
CCantor Fitzgerald
Neutral → Overweight$30.25 → $22+769.6%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SIMON IRWIN DPresident and CEOAug 26 '26Option Exercise0.001,212,16801,734,920Aug 27 08:00 PM
Merton Carl AChief Financial OfficerAug 26 '26Option Exercise0.00168,4520276,646Aug 27 08:00 PM
Gendel MitchellGlobal General CounselAug 26 '26Option Exercise0.00160,3040258,392Aug 27 07:59 PM
FALTISCHEK DENISE MChief Strategy OfficerAug 26 '26Option Exercise0.00178,2210288,657Aug 27 07:59 PM
Gendel MitchellGlobal General CounselAug 06 '26Buy4.432,50011,075124,883Aug 07 09:29 AM
Merton Carl AChief Financial OfficerAug 04 '26Buy4.6210,00046,200139,753Aug 04 01:36 PM
FALTISCHEK DENISE MChief Strategy OfficerAug 03 '26Buy4.782,50011,950141,285Aug 04 10:58 AM
SIMON IRWIN DPresident and CEOJul 30 '26Option Exercise0.00117,6470801,666Jul 31 05:53 PM
SIMON IRWIN DPresident and CEOJul 29 '26Option Exercise0.00428,4480911,097Jul 31 05:53 PM
Merton Carl AChief Financial OfficerJul 30 '26Option Exercise0.0016,6560138,914Jul 31 05:53 PM
Merton Carl AChief Financial OfficerJul 29 '26Option Exercise0.0060,4170152,467Jul 31 05:53 PM
Gendel MitchellGlobal General CounselJul 30 '26Option Exercise0.0024,3790135,304Jul 31 05:53 PM
Gendel MitchellGlobal General CounselJul 29 '26Option Exercise0.0087,4400157,269Jul 31 05:53 PM
FALTISCHEK DENISE MChief Strategy OfficerJul 30 '26Option Exercise0.0026,1200152,629Jul 31 05:52 PM
FALTISCHEK DENISE MChief Strategy OfficerJul 29 '26Option Exercise0.0093,6850176,163Jul 31 05:52 PM
Persofsky RenahDirectorJul 29 '26Option Exercise0.0043,1040176,909Jul 30 04:26 PM
Looney Thomas P.DirectorJul 29 '26Option Exercise0.0043,1040397,520Jul 30 04:26 PM
Herhalt Johann MichaelDirectorJul 29 '26Option Exercise0.0043,1040217,113Jul 30 04:26 PM
Cohen Steven MichaelDirectorJul 29 '26Option Exercise0.0043,104055,542Jul 30 04:25 PM
Clanachan David FDirectorJul 29 '26Option Exercise0.0043,1040214,063Jul 30 04:24 PM
Hopkinson David G.DirectorJul 29 '26Option Exercise0.0043,104043,104Jul 30 04:24 PM
Hopkinson David G.DirectorApr 21 '26Sale6.9433,556232,8790Apr 22 05:30 PM
Hopkinson David G.DirectorApr 21 '26Proposed Sale6.9433,556232,872Apr 21 04:15 PM
Cohen Steven MichaelDirectorJan 07 '26Option Exercise8.9912,438111,81812,438Jan 08 04:24 PM
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.
PresidentMr. Irwin David Simon
CBVMr. Carl A. Merton CA
Chief Administrative Officer & CFO of InternationalMr. Roger Savell
Global General Counsel & Corporate SecretaryMr. Mitchell S. Gendel J.D.
Chief Strategy Officer and Head of M&AMs. Denise Menikheim Faltischek